There are 3163 resources available
1542MO - Mapping the scale of off-label use in oncology: An important step in harmonising access
Presenter: Hans Timmer
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
LBA78 - Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial
Presenter: Hans Gelderblom
Session: Proffered paper session: Sarcoma
Resources:
Abstract
Slides
Webcast
Discussion
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Webcast
Novel systemic therapeutic approaches in mCRC
Presenter: Maria Elena Elez Fernandez
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
Patients with liver metastases
Presenter: René Adam
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
AI and machine learning to identify early phase clinical trial biomarkers
Presenter: Jakob Kather
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Q&A and discussion
Session: Treatment of difficult lymphomas
Resources:
Webcast
What about long-term toxicities?
Presenter: Eleonora Ghisoni
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
Q&A and discussion
Session: How Real World Data (RWD) are transforming oncology
Resources:
Webcast
Discussion
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Webcast